EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Poly(ADP-ribose) Polymerase Inhibitor Talazoparib Inhibits DNA Damage Repair in Breast Cancer Cell Lines With or Without BRCA1/2 Mutation

Miso Lee iD, Kyung-Hun Lee iD, Ahrum Min iD, Sujin Ham iD, Jihyeon Moon iD, Yu-Jin Kim iD, Hae Min Hwang iD, Youlim Noh iD, Eunice Yoojin Lee iD, Hye Yeon Park iD, Jiwon Koh iD, Changhee Park iD und 2 weitere

Journal of Breast Cancer · 2026 · 29 (5) · 395

DOI: 10.4048/jbc.2026.0085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Breast Cancer, 2026. Verfasst von Miso Lee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Institute, Seoul National University, Seoul, Korea. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Breast NeoplasmsDNA DamagePoly(ADP-ribose) Polymerase InhibitorsRecombinational DNA RepairTalazoparib

Autor:innen und Institutionen

  • Cancer Research Institute, Seoul National University, Seoul, Korea.
  • Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
  • Department of Internal Medicine and Translational Medicine, Seoul National University College of Medicine, Seoul, Korea. kyunghunlee@snu.ac.kr.
  • Interdisciplinary Programs in Cancer Biology Major, Seoul National University Graduate School, Seoul, Korea.
  • Department of Internal Medicine, University of California San Francisco, San Francisco, USA.
  • Department of Internal Medicine and Translational Medicine, Seoul National University College of Medicine, Seoul, Korea.

ORCID-Profile: Miso Lee, Kyung-Hun Lee, Ahrum Min, Sujin Ham, Jihyeon Moon, Yu-Jin Kim, Hae Min Hwang, Youlim Noh, Eunice Yoojin Lee, Hye Yeon Park, Jiwon Koh, Changhee Park, Dae-Won Lee, Seock-Ah Im

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Lee, M., Lee, K. H., Min, A., Ham, S., Moon, J., Kim, Y. J., Hwang, H. M., Noh, Y., Lee, E. Y., Park, H. Y., Koh, J., Park, C., Lee, D. W., & Im, S. A. (2026). Poly(ADP-ribose) Polymerase Inhibitor Talazoparib Inhibits DNA Damage Repair in Breast Cancer Cell Lines With or Without BRCA1/2 Mutation. Journal of Breast Cancer, 29(5), 395. https://doi.org/10.4048/jbc.2026.0085

Vancouver

Lee M, Lee KH, Min A, Ham S, Moon J, Kim YJ, et al. Poly(ADP-ribose) Polymerase Inhibitor Talazoparib Inhibits DNA Damage Repair in Breast Cancer Cell Lines With or Without BRCA1/2 Mutation. Journal of Breast Cancer. 2026;29(5):395. doi:10.4048/jbc.2026.0085

BibTeX
@article{Lee2026,
  author = {Lee, Miso and Lee, Kyung-Hun and Min, Ahrum and Ham, Sujin and Moon, Jihyeon and Kim, Yu-Jin and Hwang, Hae Min and Noh, Youlim and Lee, Eunice Yoojin and Park, Hye Yeon and Koh, Jiwon and Park, Changhee and Lee, Dae-Won and Im, Seock-Ah},
  title = {Poly(ADP-ribose) Polymerase Inhibitor Talazoparib Inhibits DNA Damage Repair in Breast Cancer Cell Lines With or Without BRCA1/2 Mutation},
  journal = {Journal of Breast Cancer},
  year = {2026},
  volume = {29},
  number = {5},
  pages = {395},
  doi = {10.4048/jbc.2026.0085}
}
Kostenlos starten →